Tonix Pharmaceuticals Holding Corp (TNXP)
NASDAQ · Healthcare
Tonix Pharmaceuticals Holding Corp Income Statement 2023–2025
| Dec 2025 | Dec 2024 | Dec 2023 | |
|---|---|---|---|
| Revenues | |||
| Revenue | 13.1M | 10.1M | 7.8M |
| Gross Profit | 6.5M | 2.3M | 3.0M |
| Profitability | |||
| Operating Income | -125.7M | -136.7M | -118.4M |
| EBITDA | -123.8M | -133.3M | -114.1M |
| Net Income | -124.0M | -130.0M | -116.7M |
| Per Share Data | |||
| EPS (diluted) | $-14.57 | $-176.60 | $-14720.25 |
| Shares Outstanding (dil.) | 9M | 1M | 0M |
Tonix Pharmaceuticals Holding Corp Income Statement — FAQ
Tonix Pharmaceuticals Holding Corp (TNXP) income statement over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TNXP's income statement history?
The chart and table above show Tonix Pharmaceuticals Holding Corp's income statement by year and by quarter, including the growth rate.